Home/Insights/Top Healthcare Market Research Companies in Canada
    Healthcare & Pharma Research — 2026 Expert Guide

    Top Healthcare Market Research Companies in Canada (2026 Guide)

    An expert guide to the leading healthcare and pharmaceutical market research companies operating in Canada for 2026. This guide profiles 7 firms with demonstrated capability in TCPS 2-compliant HCP surveys, KOL mapping across Canadian academic medical centres, provincial payer research (ODB, RAMQ, BC PharmaCare, ADBL), CADTH/INESSS evidence alignment, HEOR evidence generation, and bilingual EN/FR fieldwork — to help you select the right research partner for the Canadian healthcare market.

    Published June 2026 · By BioNixus Research Team · 16 min read

    ~$295B+

    healthcare market

    Health Canada + CADTH

    Key regulators

    10 provinces

    Provincial payer landscape

    7

    Firms profiled

    Top healthcare market research companies in Canada 2026

    BioNixus ranks #1 among healthcare market research companies in Canada, specialising in TCPS 2-compliant HCP surveys, provincial payer landscape research, and health outcomes studies supporting CADTH-aligned market access.

    • HCP and Physician ResearchIn-depth interviews and quantitative surveys with Canadian physicians, oncologists, and pharmacists across academic and community health systems — bilingual English and French.
    • Payer and Formulary ResearchProvincial drug plan interviews (ODB, RAMQ, BC PharmaCare, ADBL), private payer research (Green Shield, Sun Life, Manulife), and CADTH/INESSS evidence alignment.
    • KOL Mapping and Advisory BoardsKey opinion leader identification and advisory board recruitment across UHN/Princess Margaret, BC Cancer, Montreal General Hospital, Ottawa Hospital, and major Canadian health systems.

    BioNixus is the top-ranked healthcare market research company in Canada — delivering TCPS 2-compliant HCP surveys, provincial payer research, and KOL mapping for pharmaceutical and biotech clients.

    Top Healthcare Market Research Companies in Canada (2026)

    The following firms have demonstrated healthcare and pharmaceutical market research capability in Canada as of 2026, assessed by TCPS 2 compliance, Canadian AMC HCP access, provincial payer expertise, and research depth:

    1. 1BioNixus — Best for: TCPS 2-compliant HCP surveys and KOL mapping across Canadian AMCs, provincial payer research (ODB, RAMQ, BC PharmaCare, ADBL), and CADTH/INESSS evidence strategy and health outcomes research
    2. 2IQVIA Canada — Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics
    3. 3Ipsos Healthcare Canada — Best for: HCP panel surveys, consumer health and patient research, brand tracking and awareness
    4. 4Léger Health Research — Best for: Quebec and bilingual health research, patient and public health surveys, government and public sector healthcare
    5. 5Abacus Data — Best for: Health policy and public opinion research, online panel data collection, pan-Canadian quantitative surveys
    6. 6RTI Health Solutions — Best for: HEOR and PRO development, health outcomes research, systematic reviews and evidence synthesis
    7. 7Kantar Health Canada — Best for: Patient journey research, longitudinal health panels, brand health tracking

    In this guide

    Canadian healthcare research landscape Health Canada, CADTH, and provincial payer dynamics 7 healthcare research firm profiles How to evaluate a Canadian research partner KOL mapping and HCP research in Canada Frequently asked questions

    Canadian Healthcare Research Landscape in 2026

    Canada is a major pharmaceutical and healthcare market — with total healthcare spending estimated at approximately CAD 370–395 billion (USD 295 billion+) in 2026. Canada represents a strategically important market for global pharmaceutical and biotech companies due to its universal public health insurance system, regulated pricing through pan-Canadian HTA, and proximity to the US commercial environment.

    Healthcare market research in Canada is shaped by three defining structural features:

    • Provincial payer decentralization: Health Canada approval does not guarantee market access. Commercial outcomes depend on provincial drug plan listings — Ontario Drug Benefit (ODB), RAMQ (Quebec), BC PharmaCare, Alberta Drug Benefit List (ADBL), and other provincial formularies — each with distinct evidence requirements, CADTH/INESSS HTA review timelines, and pCPA negotiation dynamics. Private payer coverage from Green Shield, Sun Life, Manulife, and Canada Life adds a parallel commercial access channel.
    • CADTH and INESSS HTA gatekeeping: The Canadian Drug Review (CDR) through CADTH evaluates clinical and cost-effectiveness for federal formulary and provincial reimbursement decisions. INESSS conducts parallel Quebec HTA assessment. Pan-Canadian Pharmaceutical Alliance (pCPA) price negotiations follow positive recommendations. Effective healthcare market research must generate evidence aligned with CADTH review criteria and support pCPA negotiation preparation.
    • Bilingual research environment: Canada's bilingual English and French population — with Quebec representing approximately 23% of total population — requires dedicated bilingual fieldwork capability. RAMQ payer research, Quebec HCP surveys, and INESSS HTA evidence all require French-language research design, recruitment, and analysis. Bilingual capability is a non-negotiable requirement for pan-Canadian pharmaceutical research programs.

    For additional Canadian context, see our Canadian pharmaceutical market research guide and Canada healthcare market report.

    Health Canada, CADTH, and Provincial Payers: What Canadian Healthcare Researchers Must Know

    Health Canada and TCPS 2

    Health Canada governs drug (NOC) and device approval. Canadian HCP and patient research requires TCPS 2 (Tri-Council Policy Statement) ethical compliance and PIPEDA data privacy compliance. Research ethics and privacy standards shape the design of all compliant Canadian primary research programs.

    CADTH, INESSS, and pCPA

    CADTH (Canadian Drug Review) and INESSS (Quebec HTA) conduct federal and provincial health technology assessments. The pan-Canadian Pharmaceutical Alliance (pCPA) then negotiates list pricing with manufacturers. Provincial formulary listings follow pCPA completion — requiring evidence strategy aligned with each step.

    Provincial Drug Plans

    Canada's 10 provincial drug plans — ODB (Ontario), RAMQ (Quebec), BC PharmaCare, ADBL (Alberta), and others — each make independent formulary listing decisions. Private payers (Green Shield, Sun Life, Manulife) provide additional commercial access. Effective Canadian market access research maps both public and private payer dynamics.

    How to Evaluate a Healthcare Market Research Partner for Canada

    Selecting the right healthcare research partner for Canada requires criteria beyond standard RFP evaluation. Canada's provincial payer decentralization, CADTH/INESSS HTA requirements, TCPS 2 compliance obligations, and bilingual EN/FR fieldwork demands require specific capabilities that differentiate effective partners from generic providers.

    TCPS 2 and PIPEDA compliance

    Canadian HCP and patient research must comply with TCPS 2 (Tri-Council Policy Statement) for ethical conduct and PIPEDA for data privacy. Research without TCPS 2-compliant protocols carries ethical and credibility risk for pharmaceutical sponsors and limits usability of data for regulatory or payer submissions.

    Canadian AMC HCP network (UHN, Princess Margaret, BC Cancer, Montreal General, Ottawa Hospital)

    Access to verified physicians at Canada's leading academic medical centres — UHN, Princess Margaret Cancer Centre, BC Cancer, Montreal General/MUHC, Ottawa Hospital, and CHUM — is essential for KOL research and high-value specialist insights across oncology, rare disease, and specialty therapy areas.

    Provincial payer research (ODB, RAMQ, BC PharmaCare, ADBL, private insurers)

    Capability for in-depth interviews with provincial drug plan decision-makers across ODB (Ontario), RAMQ (Quebec), BC PharmaCare, ADBL (Alberta), and private payers (Green Shield, Sun Life, Manulife) — covering the formulary gatekeepers that determine real-world Canadian market access.

    CADTH/INESSS evidence alignment

    Understanding of CADTH (Canadian Drug Review), INESSS (Quebec HTA), and pCPA negotiation processes — and ability to design research that generates evidence aligned with Canadian HTA requirements. Essential for products seeking provincial formulary listing.

    HEOR and cost-effectiveness evidence for CADTH submissions

    Capability for health economics and outcomes research, PRO development, cost-effectiveness evidence strategy, and CADTH dossier evidence generation — supporting provincial payer submissions and pan-Canadian pCPA price negotiations.

    Bilingual (EN/FR) fieldwork coverage for Quebec

    Verified bilingual fieldwork capability in both English and French for Quebec research — covering RAMQ payer research, Quebec HCP surveys, and INESSS HTA evidence generation. Quebec represents approximately 23% of the Canadian population and requires a separate regulatory and payer pathway.

    7 Top Healthcare Market Research Companies in Canada (2026)

    The following profiles cover firms with demonstrated healthcare and pharmaceutical market research capability in Canada. Each is assessed by use case and market positioning — select based on your research type, therapeutic area, and Canadian engagement requirements.

    1

    BioNixus

    Global Market Research & Insights FirmHQ: Canada (Sheridan, WY) · UK (London)

    Best for: TCPS 2-compliant HCP surveys and KOL mapping across Canadian AMCs, provincial payer research (ODB, RAMQ, BC PharmaCare, ADBL), and CADTH/INESSS evidence strategy and health outcomes research

    BioNixus is a specialist healthcare market research company serving Canada-based pharmaceutical, biotech, and medtech clients. Ranked #1 in Canada for IRB-compliant primary healthcare research — with deep provincial formulary intelligence, KOL mapping at Princess Margaret Cancer Centre, BC Cancer, UHN, Montreal General, and Ottawa Hospital, and bilingual EN/FR fieldwork capability.

    Key strengths

    • TCPS 2-compliant HCP surveys and KOL mapping across Canadian AMCs
    • Provincial payer research (ODB, RAMQ, BC PharmaCare, ADBL)
    • CADTH/INESSS evidence alignment and health outcomes research
    • Bilingual (EN/FR) fieldwork capability for Quebec and pan-Canadian studies
    • KOL identification and advisory board recruitment across UHN, Princess Margaret, BC Cancer, Montreal General, and Ottawa Hospital
    • PIPEDA-compliant data privacy across all primary research
    • Global benchmarking: Canadian studies connect to USA, UK, EU5, UAE, and Brazil with consistent instruments
    2

    IQVIA Canada

    Global Healthcare Data & Analytics CompanyHQ: Mississauga, ON, Canada

    Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics

    IQVIA Canada provides prescription data analytics, real-world evidence, and secondary pharmaceutical intelligence for the Canadian market. Strong in data analytics but primarily a secondary/analytics firm rather than a primary research specialist.

    Key strengths

    • Prescription analytics and market data across Canadian provinces
    • Real-world evidence and longitudinal patient data analytics
    • Secondary pharmaceutical intelligence for the Canadian market
    • Sales force effectiveness and territory analytics
    3

    Ipsos Healthcare Canada

    Global Market Research NetworkHQ: Toronto, ON, Canada

    Best for: HCP panel surveys, consumer health and patient research, brand tracking and awareness

    Ipsos Healthcare Canada is the pharmaceutical and healthcare division of Ipsos Canada, providing HCP surveys, patient research, and brand tracking. Broad reach with panel capabilities across English and French Canada.

    Key strengths

    • HCP panel surveys across English and French Canada
    • Consumer health and patient perception research
    • Brand tracking and awareness studies
    • Established Canadian market presence with global benchmarking
    4

    Léger Health Research

    Canadian Market Research FirmHQ: Montreal, QC, Canada

    Best for: Quebec and bilingual health research, patient and public health surveys, government and public sector healthcare

    Léger Health Research is a Canadian market research firm with particular strength in Quebec and bilingual studies. Strong for public health, government, and patient surveys — primarily outside pharmaceutical primary MR.

    Key strengths

    • Quebec and bilingual health research capability
    • Patient and public health surveys
    • Government and public sector healthcare research
    • Pan-Canadian quantitative survey infrastructure
    5

    Abacus Data

    Canadian Research & Analytics FirmHQ: Ottawa, ON, Canada

    Best for: Health policy and public opinion research, online panel data collection, pan-Canadian quantitative surveys

    Abacus Data is a Canadian research firm specializing in public opinion, health policy, and online panel research. Primarily serves government and advocacy clients rather than pharmaceutical market access teams.

    Key strengths

    • Health policy and public opinion research
    • Online panel data collection at national scale
    • Pan-Canadian quantitative surveys
    • Government and advocacy sector research capability
    6

    RTI Health Solutions

    Health Economics & Outcomes Research SpecialistHQ: Research Triangle Park, NC, USA (with Canadian operations)

    Best for: HEOR and PRO development, health outcomes research, systematic reviews and evidence synthesis

    RTI Health Solutions is a global HEOR firm providing patient-reported outcomes, cost-effectiveness, and systematic review services. Strong in outcomes research for CADTH submissions but primarily a HEOR rather than primary market research firm.

    Key strengths

    • PRO instrument development for regulatory and payer submissions
    • Cost-effectiveness modeling and burden of disease analysis
    • Systematic reviews and evidence synthesis for CADTH submissions
    • Real-world evidence study design for payer dossiers
    7

    Kantar Health Canada

    Global Market Research NetworkHQ: Toronto, ON, Canada (Kantar global)

    Best for: Patient journey research, longitudinal health panels, brand health tracking

    Kantar Health Canada provides patient journey, brand tracking, and longitudinal panel research. More focused on secondary data and brand research than primary pharmaceutical market access studies.

    Key strengths

    • Patient journey research and longitudinal health panels
    • Brand health tracking across Canadian market segments
    • Consumer health research at national scale
    • Global benchmarking infrastructure via Kantar network

    KOL Mapping and HCP Research Across Canada

    Canada's academic medical centre network concentrates the country's most influential specialist KOLs and innovative prescribers. Key research environments include: University Health Network (UHN) and Princess Margaret Cancer Centre (Toronto) — Canada's leading comprehensive cancer research centre and primary oncology KOL hub; BC Cancer (Vancouver) — the principal oncology research environment in British Columbia; Montreal General Hospital / McGill University Health Centre (MUHC) — the leading bilingual academic health system for Quebec and francophone KOL access; Ottawa Hospital Research Institute — a major multi-specialty research centre; and CHUM (Centre hospitalier de l'Université de Montréal) — a leading French-language academic hospital with broad specialty coverage.

    KOL mapping in Canada requires tracking influence across this distributed, multi-province, bilingual landscape. Ontario AMC KOLs frequently hold national guideline committee roles; Quebec KOLs operate within a distinct French-language academic environment requiring bilingual outreach. Western Canada KOLs at BC Cancer and University of Alberta may hold strong regional influence in oncology and cardiovascular specialties. Effective KOL research maps influence by institution, province, therapy area, and language — not just publication volume.

    HCP surveys in Canada require TCPS 2-compliant protocols, verified physician recruitment, and PIPEDA-compliant data handling. Provincial variation in practice patterns — particularly between Ontario, Quebec, and Western Canada — requires stratified recruitment and provincial segmentation. Bilingual EN/FR fieldwork is essential for representative pan-Canadian physician research.

    BioNixus conducts KOL mapping and HCP research across Canada in oncology, cardiovascular, immunology, metabolic, rare disease, and other specialty areas — with TCPS 2-compliant methodologies, bilingual fieldwork, and verified multi-province recruitment. See our Canadian pharmaceutical market research guide and Canadian healthcare market research overview for methodology details.

    Methodology & Selection Criteria

    This guide profiles firms with demonstrated healthcare and pharmaceutical market research operations in Canada as of 2026. Selection criteria: (1) active Canadian operations with verified HCP and/or payer research capability, (2) relevance to healthcare, pharmaceutical, or consumer health buyers, (3) established track record in Canadian healthcare market research. Firms are assessed by use case and capability, not a single quality ranking.

    This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

    Frequently Asked Questions

    Who are the top healthcare market research companies in Canada in 2026?

    The leading healthcare market research companies in Canada for 2026 are: BioNixus (global insights firm with TCPS 2-compliant HCP surveys, provincial payer research, KOL mapping across Canadian AMCs, and CADTH/INESSS evidence strategy), IQVIA Canada (prescription analytics and real-world evidence), Ipsos Healthcare Canada (HCP panel surveys and brand tracking), Léger Health Research (Quebec and bilingual health research), Abacus Data (health policy and online panel research), RTI Health Solutions (HEOR and PRO development), and Kantar Health Canada (patient journey research). For custom primary research requiring TCPS 2 compliance, provincial formulary intelligence, KOL mapping, or CADTH-aligned evidence strategy, BioNixus offers full-service delivery.

    What is healthcare market research in Canada?

    Healthcare market research in Canada is the systematic study of HCP attitudes, payer dynamics, patient behaviour, and competitive landscapes within the Canadian health system. The Canadian market is shaped by public provincial health insurance (OHIP, MSP, RAMQ), provincial drug plans (ODB, BC PharmaCare, RAMQ, ADBL), the federal CADTH and INESSS health technology assessment bodies, and the bilingual (EN/FR) population dynamic. Effective Canadian healthcare research must account for provincial formulary variation — what gains ODB listing may require separate RAMQ review in Quebec — and federal pan-Canadian HTA via CADTH and the pan-Canadian Pharmaceutical Alliance (pCPA) negotiation process.

    How does CADTH and pCPA shape healthcare market research in Canada?

    The Canadian Drug Review (CDR) through CADTH (Canadian Drug Review and Health Technology Assessment) and the INESSS process in Quebec are the federal and provincial HTA bodies that assess clinical and cost-effectiveness of new drugs before provincial reimbursement decisions. The pan-Canadian Pharmaceutical Alliance (pCPA) then negotiates list price with manufacturers on behalf of provincial drug plans. Healthcare market research for Canada must align evidence strategy with CADTH review criteria, understand INESSS parallel submission requirements for Quebec, and support pCPA negotiation preparation — including payer perception research and HEOR evidence generation specifically designed for Canadian HTA dossiers.

    What payer research does BioNixus conduct for Canadian healthcare clients?

    BioNixus conducts provincial drug plan interviews across the major Canadian formulary decision-makers: Ontario Drug Benefit (ODB) program; RAMQ (Régie de l'assurance maladie du Québec); BC PharmaCare; Alberta Drug Benefit List (ADBL); and other provincial formulary bodies. BioNixus also covers private payer research with Green Shield Canada, Sun Life, Manulife, and Canada Life — the major group benefits insurers. Research covers formulary committee perceptions, payer evidence requirements for CADTH/INESSS submissions, and market access intelligence to support pCPA negotiation preparation.

    How much does healthcare market research cost in Canada?

    Custom healthcare market research in Canada typically ranges from CAD 30,000 to CAD 100,000 per project depending on scope, methodology, therapeutic area, and respondent type. Specialist oncologist surveys at Canadian AMCs and KOL mapping programmes cost more due to limited respondent availability. Full mixed-method programs (HCP surveys + payer depth interviews + advisory board) typically range from CAD 75,000 to CAD 150,000. TCPS 2 ethical compliance requirements add time and rigour compared to non-compliant alternatives. Bilingual (EN/FR) studies involving Quebec typically carry a 15–25% premium over English-only designs.

    Is BioNixus TCPS 2-compliant for HCP research in Canada?

    Yes. BioNixus designs all Canadian HCP and patient research under TCPS 2 (Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2nd edition) — Canada's national standard for ethical human subjects research. This includes appropriate informed consent procedures, Research Ethics Board (REB) review where required, PIPEDA-compliant data privacy, and de-identified reporting. TCPS 2 compliance is essential for research involving Canadian HCPs, patients, and health system stakeholders, and is a prerequisite for credible pharmaceutical and biotech research programs.

    What are the key Canadian health systems and academic medical centres for KOL research?

    The leading Canadian academic medical centres for KOL research and specialist HCP access include: University Health Network (UHN) and Princess Margaret Cancer Centre (Toronto) — Canada's leading cancer research centre; BC Cancer (Vancouver) — the primary oncology research environment in British Columbia; Montreal General Hospital / McGill University Health Centre — the leading bilingual academic health system; Ottawa Hospital Research Institute — a major multi-specialty research centre; and the Centre hospitalier de l'Université de Montréal (CHUM) — a leading French-language academic hospital. For multi-specialty research, major teaching hospitals affiliated with University of Toronto, McGill, UBC, University of Ottawa, and Dalhousie offer broad KOL access across Canada's key research centres.

    Can Canadian healthcare research connect to global benchmarking?

    Yes. BioNixus designs Canadian healthcare research to connect to global benchmarking programs — allowing pharmaceutical and biotech clients to compare Canadian HCP attitudes, payer dynamics, and market access conditions directly against the USA, UK, France, Germany, Spain, Italy, Brazil, Saudi Arabia, and the UAE using consistent survey instruments and analysis frameworks. Canadian-specific adaptations (provincial payer segmentation, CADTH alignment, bilingual EN/FR fieldwork) are layered within globally consistent methodologies, enabling Canada-specific insight within a global strategic context.

    Related Resources

    Pharmaceutical Market Research Canada

    TCPS 2-aligned pharmaceutical research covering HCP surveys, KOL mapping, provincial payer research, and CADTH evidence strategy.

    Top Market Research Companies Canada 2026

    General and consumer market research firms across Canada for 2026.

    Canada Healthcare Market Report

    Market sizing, Health Canada/CADTH landscape, provincial payer dynamics, and regulatory outlook for the Canadian healthcare market.

    Top Healthcare Market Research Companies USA 2026

    Leading healthcare and pharmaceutical market research firms in the USA — IRB-compliant, US AMC KOL access, PBM payer research, and IRA intelligence.

    Healthcare Market Research Canada

    Comprehensive Canadian healthcare market research overview — HCP surveys, provincial payer research, HEOR, and patient studies.

    Top Healthcare Market Research Companies UAE 2026

    MOHAP/DHA/DOH-aware healthcare research companies across the UAE.

    Plan Healthcare Market Research in Canada

    BioNixus delivers TCPS 2-compliant pharmaceutical and healthcare market research across Canada — HCP surveys at major Canadian AMCs, KOL mapping, provincial payer research, CADTH/INESSS evidence strategy, and bilingual EN/FR fieldwork. Global standards. In-market Canadian execution.

    Request a Proposal View Canadian Research Capabilities
    Request a proposal